# Acceptability of Long-term Progestin-only Contraception in Europe

> **NCT00931827** · — · COMPLETED · sponsor: **Bayer** · enrollment: 436 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Levonorgestrel IUS (Mirena, BAY86-5028)
- **DRUG:** Implanon (Etonogestrel)

## Key facts

- **NCT ID:** NCT00931827
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931827, "Acceptability of Long-term Progestin-only Contraception in Europe". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00931827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*